Literature DB >> 33413093

Cardiovascular risk factors and mortality in hospitalized patients with COVID-19: systematic review and meta-analysis of 45 studies and 18,300 patients.

Angelo Silverio1, Marco Di Maio1, Rodolfo Citro2, Luca Esposito2, Giuseppe Iuliano2, Michele Bellino2, Cesare Baldi2, Giuseppe De Luca3, Michele Ciccarelli1, Carmine Vecchione1,4, Gennaro Galasso5.   

Abstract

BACKGROUND: A high prevalence of cardiovascular risk factors including age, male sex, hypertension, diabetes, and tobacco use, has been reported in patients with Coronavirus disease 2019 (COVID-19) who experienced adverse outcome. The aim of this study was to investigate the relationship between cardiovascular risk factors and in-hospital mortality in patients with COVID-19.
METHODS: MEDLINE, Cochrane, Web of Sciences, and SCOPUS were searched for retrospective or prospective observational studies reporting data on cardiovascular risk factors and in-hospital mortality in patients with COVID-19. Univariable and multivariable age-adjusted analyses were conducted to evaluate the association between cardiovascular risk factors and the occurrence of in-hospital death.
RESULTS: The analysis included 45 studies enrolling 18,300 patients. The pooled estimate of in-hospital mortality was 12% (95% CI 9-15%). The univariable meta-regression analysis showed a significant association between age (coefficient: 1.06; 95% CI 1.04-1.09; p < 0.001), diabetes (coefficient: 1.04; 95% CI 1.02-1.07; p < 0.001) and hypertension (coefficient: 1.01; 95% CI 1.01-1.03; p = 0.013) with in-hospital death. Male sex and smoking did not significantly affect mortality. At multivariable age-adjusted meta-regression analysis, diabetes was significantly associated with in-hospital mortality (coefficient: 1.02; 95% CI 1.01-1.05; p = 0.043); conversely, hypertension was no longer significant after adjustment for age (coefficient: 1.00; 95% CI 0.99-1.01; p = 0.820). A significant association between age and in-hospital mortality was confirmed in all multivariable models.
CONCLUSIONS: This meta-analysis suggests that older age and diabetes are associated with higher risk of in-hospital mortality in patients infected by SARS-CoV-2. Conversely, male sex, hypertension, and smoking did not independently correlate with fatal outcome.

Entities:  

Keywords:  COVID-19; Cardiovascular risk factors; Diabetes; Hypertension; Mortality; Novel coronavirus; Outcome; SARS-CoV-2; Smoking

Mesh:

Year:  2021        PMID: 33413093      PMCID: PMC7789083          DOI: 10.1186/s12872-020-01816-3

Source DB:  PubMed          Journal:  BMC Cardiovasc Disord        ISSN: 1471-2261            Impact factor:   2.298


  65 in total

1.  Critical Illness in Patients With COVID-19: Mounting an Effective Clinical and Research Response.

Authors:  Deborah J Cook; John C Marshall; Robert A Fowler
Journal:  JAMA       Date:  2020-04-28       Impact factor: 56.272

2.  Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy.

Authors:  Graziano Onder; Giovanni Rezza; Silvio Brusaferro
Journal:  JAMA       Date:  2020-05-12       Impact factor: 56.272

3.  Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.

Authors:  Chaolin Huang; Yeming Wang; Xingwang Li; Lili Ren; Jianping Zhao; Yi Hu; Li Zhang; Guohui Fan; Jiuyang Xu; Xiaoying Gu; Zhenshun Cheng; Ting Yu; Jiaan Xia; Yuan Wei; Wenjuan Wu; Xuelei Xie; Wen Yin; Hui Li; Min Liu; Yan Xiao; Hong Gao; Li Guo; Jungang Xie; Guangfa Wang; Rongmeng Jiang; Zhancheng Gao; Qi Jin; Jianwei Wang; Bin Cao
Journal:  Lancet       Date:  2020-01-24       Impact factor: 79.321

4.  Potential association between COVID-19 mortality and health-care resource availability.

Authors:  Yunpeng Ji; Zhongren Ma; Maikel P Peppelenbosch; Qiuwei Pan
Journal:  Lancet Glob Health       Date:  2020-02-25       Impact factor: 26.763

5.  Estimating Risk for Death from Coronavirus Disease, China, January-February 2020.

Authors:  Kenji Mizumoto; Gerardo Chowell
Journal:  Emerg Infect Dis       Date:  2020-06-17       Impact factor: 6.883

6.  Distinct characteristics of COVID-19 patients with initial rRT-PCR-positive and rRT-PCR-negative results for SARS-CoV-2.

Authors:  Jin-Jin Zhang; Yi-Yuan Cao; Xiang Dong; Bin-Chen Wang; Mei-Yan Liao; Jun Lin; You-Qin Yan; Cezmi A Akdis; Ya-Dong Gao
Journal:  Allergy       Date:  2020-04-27       Impact factor: 13.146

7.  Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19.

Authors:  Yuwei Liu; Xuebei Du; Jing Chen; Yalei Jin; Li Peng; Harry H X Wang; Mingqi Luo; Ling Chen; Yan Zhao
Journal:  J Infect       Date:  2020-04-10       Impact factor: 6.072

8.  Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019 - United States, February 12-March 28, 2020.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2020-04-03       Impact factor: 17.586

9.  Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19).

Authors:  Tao Guo; Yongzhen Fan; Ming Chen; Xiaoyan Wu; Lin Zhang; Tao He; Hairong Wang; Jing Wan; Xinghuan Wang; Zhibing Lu
Journal:  JAMA Cardiol       Date:  2020-07-01       Impact factor: 14.676

10.  Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms.

Authors:  Xi Jin; Jiang-Shan Lian; Jian-Hua Hu; Jianguo Gao; Lin Zheng; Yi-Min Zhang; Shao-Rui Hao; Hong-Yu Jia; Huan Cai; Xiao-Li Zhang; Guo-Dong Yu; Kai-Jin Xu; Xiao-Yan Wang; Jue-Qing Gu; Shan-Yan Zhang; Chan-Yuan Ye; Ci-Liang Jin; Ying-Feng Lu; Xia Yu; Xiao-Peng Yu; Jian-Rong Huang; Kang-Li Xu; Qin Ni; Cheng-Bo Yu; Biao Zhu; Yong-Tao Li; Jun Liu; Hong Zhao; Xuan Zhang; Liang Yu; Yong-Zheng Guo; Jun-Wei Su; Jing-Jing Tao; Guan-Jing Lang; Xiao-Xin Wu; Wen-Rui Wu; Ting-Ting Qv; Dai-Rong Xiang; Ping Yi; Ding Shi; Yanfei Chen; Yue Ren; Yun-Qing Qiu; Lan-Juan Li; Jifang Sheng; Yida Yang
Journal:  Gut       Date:  2020-03-24       Impact factor: 23.059

View more
  23 in total

1.  Barthel's Index: A Better Predictor for COVID-19 Mortality Than Comorbidities.

Authors:  João Cordeiro da Costa; Maria Conceição Manso; Susana Gregório; Márcia Leite; João Moreira Pinto
Journal:  Tuberc Respir Dis (Seoul)       Date:  2022-06-23

2.  Increased Risk of Postoperative Mortality Associated With Prior COVID-19 Infection.

Authors:  Connie C Shao; M Chandler McLeod; Suneetha Thogaripally; Michael J Mugavero; Lauren T Gleason; Isabel C Dos Santos Marques; Daniel I Chu; Drew J Gunnells
Journal:  Am J Prev Med       Date:  2022-07       Impact factor: 6.604

Review 3.  Cardiovascular Involvement in COVID-19: What Sequelae Should We Expect?

Authors:  Maria Vincenza Polito; Angelo Silverio; Michele Bellino; Giuseppe Iuliano; Marco Di Maio; Carmine Alfano; Patrizia Iannece; Nicolino Esposito; Gennaro Galasso
Journal:  Cardiol Ther       Date:  2021-06-30

4.  Cardiovascular risk factors and clinical outcomes of patients hospitalized with COVID-19 pneumonia in Somalia.

Authors:  Mohammed A M Ahmed; Ahmed Mohamud Hussein; Aweis Ahmed Moalim Abdullahi; Abdirizak Yusuf Ahmed; Hamdi M A Hussain; Abdiaziz Mohamed Ali; Abdulqadir Abdinur Barre; Farhia Mohamud Yusuf; Ronald Olum; Senai Goitom Sereke; Maisa Ahmed Elfadul; Robert Colebunders; Felix Bongomin
Journal:  Ther Adv Infect Dis       Date:  2022-04-25

Review 5.  Association of COVID-19 transmission with high levels of ambient pollutants: Initiation and impact of the inflammatory response on cardiopulmonary disease.

Authors:  Angela Lai; Megan L Chang; Ryan P O'Donnell; Changcheng Zhou; Jennifer A Sumner; Tzung K Hsiai
Journal:  Sci Total Environ       Date:  2021-03-16       Impact factor: 7.963

6.  Chronic Oral Anticoagulation and Clinical Outcome in Hospitalized COVID-19 Patients.

Authors:  Vincenzo Russo; Roberta Bottino; Antonello D'Andrea; Angelo Silverio; Marco Di Maio; Paolo Golino; Gerardo Nigro; Orazio Valsecchi; Emilio Attena; Mario Enrico Canonico; Gennaro Galasso; Guido Parodi; Fernando Scudiero
Journal:  Cardiovasc Drugs Ther       Date:  2021-05-14       Impact factor: 3.947

7.  Characteristics and outcomes of patients with COVID-19 with and without prevalent hypertension: a multinational cohort study.

Authors:  Carlen Reyes; Andrea Pistillo; Sergio Fernández-Bertolín; Martina Recalde; Elena Roel; Diana Puente; Anthony G Sena; Clair Blacketer; Lana Lai; Thamir M Alshammari; Waheed-Ui-Rahman Ahmed; Osaid Alser; Heba Alghoul; Carlos Areia; Dalia Dawoud; Albert Prats-Uribe; Neus Valveny; Gabriel de Maeztu; Luisa Sorlí Redó; Jordi Martinez Roldan; Inmaculada Lopez Montesinos; Lisa M Schilling; Asieh Golozar; Christian Reich; Jose D Posada; Nigam Shah; Seng Chan You; Kristine E Lynch; Scott L DuVall; Michael E Matheny; Fredrik Nyberg; Anna Ostropolets; George Hripcsak; Peter R Rijnbeek; Marc A Suchard; Patrick Ryan; Kristin Kostka; Talita Duarte-Salles
Journal:  BMJ Open       Date:  2021-12-22       Impact factor: 2.692

Review 8.  Emergency Department Management of Hypertension in the Context of COVID-19.

Authors:  Sara W Heinert; Renee Riggs; Heather Prendergast
Journal:  Curr Hypertens Rep       Date:  2022-01-25       Impact factor: 4.592

9.  The vicious cycle: a history of obesity and COVID-19.

Authors:  Jacek Bil; Olga Możeńska
Journal:  BMC Cardiovasc Disord       Date:  2021-07-06       Impact factor: 2.298

10.  Risk factors for mortality of adult patients with COVID-19 hospitalised in an emerging country: a cohort study.

Authors:  Alfonso M Cueto-Manzano; María C Espinel-Bermúdez; Sandra O Hernández-González; Enrique Rojas-Campos; Arnulfo H Nava-Zavala; Clotilde Fuentes-Orozco; Luz Ma A Balderas-Peña; Alejandro González-Ojeda; Laura Cortes-Sanabria; Mario A Mireles-Ramírez; José J Ramírez-Márquez; Porfirio E Martínez-Gutiérrez; Maribel Ávila-Morán; Ramón I De-Dios-Pérez; Carlos Acosta-Ramírez; Hugo R Hernández-García
Journal:  BMJ Open       Date:  2021-07-19       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.